INFORMATION FOR
News
New research from a group of Yale physicians sheds light on the clinical reasoning strategies used by expert clinicians in handling complex medical cases.
Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...
After a decade without success, the Connecticut legislature is again considering a bill to allow physicians to assist patients in the taking of their own lives. I am not a legislator, but a practicing academic physician and as such I ask three questions when considering the merits of legislation: (1) What problem is it trying to solve? (2) Is it enforceable if safeguards are not followed? (3) Are there better alternatives?
After 37 years in medicine, Auguste Fortin VI, MD, MPH, MACP, professor of medicine (general medicine) will retire on June 30, 2022.
Andre N. Sofair, MD, and Barry J. Wu, MD discuss have been following and contesting "the relentless pursuit of legislation to legalize physician-assisted death in our state..."
CT Viewpoints: Bill’s death is another chance to improve the lives of those suffering
Nephrologist / Global Health Trailblazer Dr. Asghar Rastegar Retiring July 1
Internal Medicine Educators Honored At 2020 YSM Commencement
On May 18, the 113 graduates of the Yale School of Medicine (YSM) MD Class of 2020 were celebrated in an hour-long virtual Commencement ceremony, an event that reflected tremendous collaboration among YSM students, faculty, and staff.
Yale Medicine physicians describe the recovery path they have seen for patients experiencing 'mild to moderate' forms of the disease.
Physicians once relied on seeing, hearing and touching a patient to make a diagnosis. Technology has enhanced and sometimes replaced those skills, but many doctors lament their decline.
The pressures of the real world will challenge their graduation-day idealism, Herbert S. Chase Jr.
Students weren’t the only ones celebrating when the School of Medicine held its Commencement ceremonies on Harkness Lawn last May. Many of their mentors were also given recognition as great educators.
Even before last fall’s anthrax attacks, physicians and public health experts worried about the nation’s ability to identify and respond to outbreaks of infectious disease. In response to a 1992 report from the Institute of Medicine, the Centers for Disease Control and Prevention (CDC) had begun..
Unexplained illnesses and deaths occur relatively frequently in the United States, according to a new study by Yale researchers.
When the breakthrough cancer drug Gleevec made headlines, Yale Cancer Center Director Vincent T. DeVita Jr.
A Yale Medicine roundtable. At the 2001 annual meeting of the American Association for the Advancement of Science last February in San Francisco, an audience member asked a panel of experts on bioterrorism why the world had yet to see a major biological attack.
A method called prospective surveillance, which studies unexplained illness and death due to possibly infectious causes, allowed for earlier detection of emerging and reemerging infections in 73 percent of cases, Yale researchers conclude in a new study.